Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...
NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...
FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies NEW YORK, NY, UNITED STATES, January 12, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results